Abstract
OBJECTIVE: To update the mortality experience of a cohort of 8508 workers with potential exposure to acrylamide at three plants in the United States from 1984-94. METHODS: Analyses of standardised mortality ratios (SMR) with national and local rates and relative risk (RR) regression modelling were performed to assess site specific cancer risks by demographic and work history factors, and exposure indicators for acrylamide and muriatic acid. RESULTS: For the 1925-94 study period, excess and deficit overall mortality risks were found for cancer sites of interest: brain and other central nervous system (CNS) (SMR 0.65, 95% confidence interval (95% CI) 0.36 to 1.09), thyroid gland (SMR 2.11, 95% CI 0.44 to 6.17), testis and other male genital organs (SMR 0.28, 95% CI 0.01 to 1.59), and cancer of the respiratory system (SMR 1.10, 95% CI 0.99 to 1.22); however, none was significant or associated with exposure to acrylamide. A previously reported excess mortality risk of cancer of the respiratory system at one plant remained increased among workers with potential exposure to muriatic acid (RR 1.50, 95% CI 0.86 to 2.59), but was only slightly increased among workers exposed or unexposed to acrylamide. In an exploratory exposure-response analysis of rectal, oesophageal, pancreatic, and kidney cancer, we found increased SMRs for some categories of exposure to acrylamide, but little evidence of an exposure-response relation. A significant 2.26-fold risk (95% CI 1.03 to 4.29) was found for pancreatic cancer among workers with cumulative exposure to acrylamide > 0.30 mg/m3.years; however, no consistent exposure-response relations were detected with the exposure measures considered when RR regression models were adjusted for time since first exposure to acrylamide. CONCLUSION: The contribution of 1115 additional deaths and nearly 60,000 person-years over the 11 year follow up period corroborate the original cohort study findings of little evidence for a causal relation between exposure to acrylamide and mortality from any cancer sites, including those of initial interest. This is the most definitive study of the human carcinogenic potential of exposure to acrylamide conducted to date.
Full Text
The Full Text of this article is available as a PDF (138.0 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bull R. J., Robinson M., Laurie R. D., Stoner G. D., Greisiger E., Meier J. R., Stober J. Carcinogenic effects of acrylamide in Sencar and A/J mice. Cancer Res. 1984 Jan;44(1):107–111. [PubMed] [Google Scholar]
- Caplan R. J., Marsh G. M., Enterline P. E. A generalized effective exposure modeling program for assessing dose-response in epidemiologic investigations. Comput Biomed Res. 1983 Dec;16(6):587–596. doi: 10.1016/0010-4809(83)90044-7. [DOI] [PubMed] [Google Scholar]
- Collins J. J., Swaen G. M., Marsh G. M., Utidjian H. M., Caporossi J. C., Lucas L. J. Mortality patterns among workers exposed to acrylamide. J Occup Med. 1989 Jul;31(7):614–617. doi: 10.1097/00043764-198907000-00013. [DOI] [PubMed] [Google Scholar]
- Johnson K. A., Gorzinski S. J., Bodner K. M., Campbell R. A., Wolf C. H., Friedman M. A., Mast R. W. Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol Appl Pharmacol. 1986 Sep 15;85(2):154–168. doi: 10.1016/0041-008x(86)90109-2. [DOI] [PubMed] [Google Scholar]
- Marsh G. M., Youk A. O., Stone R. A., Sefcik S., Alcorn C. OCMAP-PLUS: a program for the comprehensive analysis of occupational cohort data. J Occup Environ Med. 1998 Apr;40(4):351–362. doi: 10.1097/00043764-199804000-00010. [DOI] [PubMed] [Google Scholar]
- Monson R. R. Analysis of relative survival and proportional mortality. Comput Biomed Res. 1974 Aug;7(4):325–332. doi: 10.1016/0010-4809(74)90010-x. [DOI] [PubMed] [Google Scholar]
- Schall L. C., Marsh G. M., Henderson V. L. A two-stage protocol for verifying vital status in large historical cohort studies. J Occup Environ Med. 1997 Nov;39(11):1097–1102. doi: 10.1097/00043764-199711000-00010. [DOI] [PubMed] [Google Scholar]
- Sobel W., Bond G. G., Parsons T. W., Brenner F. E. Acrylamide cohort mortality study. Br J Ind Med. 1986 Nov;43(11):785–788. doi: 10.1136/oem.43.11.785. [DOI] [PMC free article] [PubMed] [Google Scholar]